{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T13:26:55Z","timestamp":1767187615009,"version":"3.48.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.7759\/cureus.100483","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T13:24:18Z","timestamp":1767187458000},"source":"Crossref","is-referenced-by-count":0,"title":["Multifocal Inflammatory Myofibroblastic Tumor Presenting With Hemorrhagic Shock Due to Duodenal Invasion by a Pancreatic Head Mass: A Case Report"],"prefix":"10.7759","author":[{"given":"Issei","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh H","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Komuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuzo W","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ohizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisei","family":"Katahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kiryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/kitp.2025.148514","article-title":"Inflammatory myofibroblastic tumor of the lung: a comprehensive narrative review of clinical and therapeutic insights","volume":"22","author":"Leivaditis V","year":"2025","unstructured":"Leivaditis V, Baltagianni M, Liolis E, et al.. Inflammatory myofibroblastic tumor of the lung: a comprehensive narrative review of clinical and therapeutic insights. Kardiochir Torakochirurgia Pol. 2025, 22:32-43. 10.5114\/kitp.2025.148514","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081327","article-title":"Inflammatory myofibroblastic tumor: an updated review","volume":"17","author":"Choi JH","year":"2025","unstructured":"Choi JH. Inflammatory myofibroblastic tumor: an updated review. Cancers (Basel). 2025, 17:1327. 10.3390\/cancers17081327","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-014-0370-0","article-title":"Inflammatory myofibroblastic tumours: a pictorial review","volume":"6","author":"Cantera JE","year":"2015","unstructured":"Cantera JE, Alfaro MP, Rafart DC, Zalazar R, Muruzabal MM, Barqu\u00edn PG, P\u00e9rez IV. Inflammatory myofibroblastic tumours: a pictorial review. Insights Imaging. 2015, 6:85-96. 10.1007\/s13244-014-0370-0","journal-title":"Insights Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100768","article-title":"Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges","volume":"45","author":"Mahajan P","year":"2021","unstructured":"Mahajan P, Casanova M, Ferrari A, Fordham A, Trahair T, Venkatramani R. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021, 45:100768. 10.1016\/j.currproblcancer.2021.100768","journal-title":"Curr Probl Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700332","article-title":"Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours","volume":"37","author":"Jiang YH","year":"2009","unstructured":"Jiang YH, Cheng B, Ge MH, Cheng Y, Zhang G. Comparison of the clinical and immunohistochemical features, including anaplastic lymphoma kinase (ALK) and p53, in inflammatory myofibroblastic tumours. J Int Med Res. 2009, 37:867-77. 10.1177\/147323000903700332","journal-title":"J Int Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin CM","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007, 31:509-20. 10.1097\/01.pas.0000213393.57322.c7","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.826705","article-title":"Case report: early distant metastatic inflammatory myofibroblastic tumor harboring EML4\u2011ALK fusion gene: study of two typical cases and review of literature","volume":"9","author":"Han Q","year":"2022","unstructured":"Han Q, He X, Cui L, Qiu Y, Li Y, Chen H, Zhang H. Case report: early distant metastatic inflammatory myofibroblastic tumor harboring EML4\u2011ALK fusion gene: study of two typical cases and review of literature. Front Med (Lausanne). 2022, 9:826705. 10.3389\/fmed.2022.826705","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-023-01802-9","article-title":"Gastric inflammatory myofibroblastic tumor presented with severe anemia and inflammation: a case report","volume":"10","author":"Hiramatsu S","year":"2024","unstructured":"Hiramatsu S, Ataka R, Nakayama Y, et al.. Gastric inflammatory myofibroblastic tumor presented with severe anemia and inflammation: a case report. Surg Case Rep. 2024, 10:5. 10.1186\/s40792-023-01802-9","journal-title":"Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-016-0880-0","article-title":"Inflammatory myofibroblastic tumor of the small intestine mimicking acute appendicitis: a case report and review of the literature","volume":"10","author":"Oeconomopoulou A","year":"2016","unstructured":"Oeconomopoulou A, de Verney Y, Kanavaki K, Stefanaki K, Pavlakis K, Salakos C. Inflammatory myofibroblastic tumor of the small intestine mimicking acute appendicitis: a case report and review of the literature. J Med Case Rep. 2016, 10:100. 10.1186\/s13256-016-0880-0","journal-title":"J Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5152\/dir.2014.13348","article-title":"MRI characterization of inflammatory myofibroblastic tumors in the maxillofacial region","volume":"20","author":"Li H","year":"2014","unstructured":"Li H, Wang de L, Liu XW, Geng ZJ, Xie CM. MRI characterization of inflammatory myofibroblastic tumors in the maxillofacial region. Diagn Interv Radiol. 2014, 20:310-5. 10.5152\/dir.2014.13348","journal-title":"Diagn Interv Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1796-7","article-title":"Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report","volume":"12","author":"Na YS","year":"2018","unstructured":"Na YS, Park SG. Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report. J Med Case Rep. 2018, 12:253. 10.1186\/s13256-018-1796-7","journal-title":"J Med Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.remn.2015.09.005","article-title":"Paraneoplastic pemphigus as a first sign of metastatic retroperitoneal inflammatory myofibroblastic tumor: (18)F-FDG PET\/CT findings","volume":"35","author":"Dhull VS","year":"2016","unstructured":"Dhull VS, Passah A, Rana N, Arora S, Mallick S, Kumar R. Paraneoplastic pemphigus as a first sign of metastatic retroperitoneal inflammatory myofibroblastic tumor: (18)F-FDG PET\/CT findings. Rev Esp Med Nucl Imagen Mol. 2016, 35:260-2. 10.1016\/j.remn.2015.09.005","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu CR","year":"2015","unstructured":"Antonescu CR, Suurmeijer AJ, Zhang L, et al.. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol. 2015, 39:957-67. 10.1097\/PAS.0000000000000404","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153662","article-title":"Inflammatory myofibroblastic tumour: state of the art","volume":"14","author":"Gros L","year":"2022","unstructured":"Gros L, Dei Tos AP, Jones RL, Digklia A. Inflammatory myofibroblastic tumour: state of the art. Cancers (Basel). 2022, 14:3662. 10.3390\/cancers14153662","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomized controlled phase 3 trial","volume":"15","author":"Judson I","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, et al.. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomized controlled phase 3 trial. Lancet Oncol. 2014, 15:415-23. 10.1016\/S1470-2045(14)70063-4","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0352","article-title":"The activity of chemotherapy in inflammatory myofibroblastic tumors: a multicenter, European retrospective case series analysis","volume":"25","author":"Baldi GG","year":"2020","unstructured":"Baldi GG, Brahmi M, Lo Vullo S, et al.. The activity of chemotherapy in inflammatory myofibroblastic tumors: a multicenter, European retrospective case series analysis. Oncologist. 2020, 25:e1777-84. 10.1634\/theoncologist.2020-0352","journal-title":"Oncologist"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski JE","year":"2010","unstructured":"Butrynski JE, D'Adamo DR, Hornick JL, et al.. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010, 363:1727-33. 10.1056\/NEJMoa1007056","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.658327","article-title":"Outstanding response in a patient with ROS1-rearranged inflammatory myofibroblastic tumor of soft tissues treated with crizotinib: case report","volume":"11","author":"Comandini D","year":"2021","unstructured":"Comandini D, Catalano F, Grassi M, et al.. Outstanding response in a patient with ROS1-rearranged inflammatory myofibroblastic tumor of soft tissues treated with crizotinib: case report. Front Oncol. 2021, 11:658327. 10.3389\/fonc.2021.658327","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421637-multifocal-inflammatory-myofibroblastic-tumor-presenting-with-hemorrhagic-shock-due-to-duodenal-invasion-by-a-pancreatic-head-mass-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T13:24:19Z","timestamp":1767187459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421637-multifocal-inflammatory-myofibroblastic-tumor-presenting-with-hemorrhagic-shock-due-to-duodenal-invasion-by-a-pancreatic-head-mass-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.100483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}